Expert Interview
Discussing the Phase 3 trial results of Axsome Therapeutics AXS-12 for patients with narcolepsy
Ticker(s): AXSMInstitution: Beth Israel Deaconess Medical Center
- Associate professor of medicine at Harvard medical school, and director of the sleep center at Beth Israel Deaconess Medical Center.
- Currently manages over 60 patients with narcolepsy.
- Clinical and research interests include wearable devices, brain health in sleep disorders, hypersomnias, and complex sleep breathing and circadian syndromes.
Roughly how many patients do you currently manage with narcolepsy?
Added By: ben_adminWhat are you overall thoughts on the potential of AXS-12?
Added By: ben_adminWhat is your excitement level for AXS-12 on a scale of 1-10?
Added By: ben_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
